Mouse Anti-Human PU.1 Antibody (S-4307)

PU.1, also known as SPI1 (Spleen Focus Forming Virus Proviral Integration Oncogene), is a critical ETS-family transcription factor that serves as a master regulator of hematopoiesis, specifically governing the development, differentiation, and functional maturation of myeloid lineages (including monocytes, macrophages, and granulocytes) and B lymphocytes. Functioning by binding to specific purine-rich DNA sequences via its highly conserved ETS domain, PU.1 orchestrates complex gene regulatory networks by recruiting co-activators or co-repressors to control the expression of hundreds of target genes essential for immune cell identity, such as those encoding cytokine receptors, signaling molecules, and lineage-specific enzymes; its activity is tightly dosage-dependent, where precise expression levels determine cell fate decisions, with high levels promoting macrophage differentiation and lower levels favoring B-cell development, while its dysregulation, mutation, or aberrant overexpression is strongly implicated in various hematological malignancies, particularly acute myeloid leukemia (AML) and certain types of lymphoma, making it a pivotal molecule for understanding both normal immune system architecture and leukemogenesis.